activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650036	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1650036	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5284	Homo sapiens	Kd		
	1650037	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2200.0	CHEMBL5284	Homo sapiens	Kd	uM	2.2
Not Active	1650038	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL5284	Homo sapiens	Kd		
	1650039	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5800.0	CHEMBL5284	Homo sapiens	Kd	uM	5.8
Not Active	1650040	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL5284	Homo sapiens	Kd		
	1650041	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1100.0	CHEMBL5284	Homo sapiens	Kd	uM	1.1
Not Active	1650042	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1650043	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL5284	Homo sapiens	Kd		
	1650044	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	320.0	CHEMBL5284	Homo sapiens	Kd	uM	0.32
	1651797	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.05	CHEMBL5284	Homo sapiens	Kd	uM	0.00005
Not Active	1651798	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651799	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651800	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651801	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL5284	Homo sapiens	Kd		
	1651802	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	7500.0	CHEMBL5284	Homo sapiens	Kd	uM	7.5
Not Active	1651803	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651804	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651805	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651806	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL5284	Homo sapiens	Kd		
Not Active	1651807	CHEMBL860655	Average Binding Constant for CAMKK2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL5284	Homo sapiens	Kd		
	2136986	CHEMBL940168	Inhibition of CaM-KKbeta	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Ki	nM	29700.0	CHEMBL5284	Homo sapiens	Ki	nM	29700.0
	2136988	CHEMBL940168	Inhibition of CaM-KKbeta	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Ki	nM	13000.0	CHEMBL5284	Homo sapiens	Ki	nM	13000.0
	2137095	CHEMBL940168	Inhibition of CaM-KKbeta	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Ki	nM	1.8	CHEMBL5284	Homo sapiens	Ki	nM	1.8
	2137123	CHEMBL940168	Inhibition of CaM-KKbeta	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	IC50	nM	200.0	CHEMBL5284	Homo sapiens	IC50	nM	200.0
	2137359	CHEMBL940168	Inhibition of CaM-KKbeta	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	IC50	ug.mL-1	0.04	CHEMBL5284	Homo sapiens	IC50	ng/ml	40.0
Not Active	2302206	CHEMBL945699	Inhibition of human CAMKKbeta at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
	2470167	CHEMBL1034116	Inhibition of CAMKK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5284	Homo sapiens	INH	%	10.0
Not Evaluated	2476730	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2478569	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2478772	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5284	Homo sapiens	Activity		
	2479627	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	3.7	CHEMBL5284	Homo sapiens	Activity	%	3.7
Not Evaluated	2479830	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5284	Homo sapiens	Activity		
	2480627	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL5284	Homo sapiens	Activity	%	0.1
Not Evaluated	2480829	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2577248	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2577451	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2593656	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2593922	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2594125	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2594865	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5284	Homo sapiens	Activity		
Not Evaluated	2595068	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5284	Homo sapiens	Activity		
	2596265	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	2.8	CHEMBL5284	Homo sapiens	Activity	%	2.8
	2596468	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	35.4	CHEMBL5284	Homo sapiens	Activity	%	35.4
Not Evaluated	2597737	CHEMBL982758	Binding affinity to human CAMKK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5284	Homo sapiens	Activity		
	2635190	CHEMBL1000629	Inhibition of CAMKKb at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	50.0	CHEMBL5284	Homo sapiens	Residual_activity	%	50.0
	2635933	CHEMBL1000629	Inhibition of CAMKKb at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL5284	Homo sapiens	Residual_activity	%	100.0
	2636001	CHEMBL1000629	Inhibition of CAMKKb at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL5284	Homo sapiens	Residual_activity	%	75.0
Antagonist	2897276	CHEMBL1051267	Inhibition of CAMKKbeta in the presence of 20uM ATP	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	IC50	nM	10.0	CHEMBL5284	Homo sapiens	IC50	uM	0.01
	2899497	CHEMBL1051372	Percentage CaMKKbeta activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	82.0	CHEMBL5284	Homo sapiens	Activity	%	82.0
	2899498	CHEMBL1051372	Percentage CaMKKbeta activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	83.0	CHEMBL5284	Homo sapiens	Activity	%	83.0
Antagonist	2899499	CHEMBL1051372	Percentage CaMKKbeta activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	21.0	CHEMBL5284	Homo sapiens	Activity	%	21.0
	2899500	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	73.0	CHEMBL5284	Homo sapiens	Activity	%	73.0
Antagonist	2899501	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	30.0	CHEMBL5284	Homo sapiens	Activity	%	30.0
	2899502	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	63.0	CHEMBL5284	Homo sapiens	Activity	%	63.0
	2899503	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	60.0	CHEMBL5284	Homo sapiens	Activity	%	60.0
	2899504	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	65.0	CHEMBL5284	Homo sapiens	Activity	%	65.0
Antagonist	2899505	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	11.0	CHEMBL5284	Homo sapiens	Activity	%	11.0
	2899506	CHEMBL1061146	Percentage CaMKKbeta activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	53.0	CHEMBL5284	Homo sapiens	Activity	%	53.0
	2899507	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	90.0	CHEMBL5284	Homo sapiens	Activity	%	90.0
	2899508	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	2899509	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	73.0	CHEMBL5284	Homo sapiens	Activity	%	73.0
Antagonist	2899510	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	20.0	CHEMBL5284	Homo sapiens	Activity	%	20.0
	2899511	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	2899512	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	80.0	CHEMBL5284	Homo sapiens	Activity	%	80.0
	2899513	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
Antagonist	2899514	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	41.0	CHEMBL5284	Homo sapiens	Activity	%	41.0
Antagonist	2899515	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	50.0	CHEMBL5284	Homo sapiens	Activity	%	50.0
	2899516	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	99.0	CHEMBL5284	Homo sapiens	Activity	%	99.0
Antagonist	2899517	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	29.0	CHEMBL5284	Homo sapiens	Activity	%	29.0
	2899518	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	93.0	CHEMBL5284	Homo sapiens	Activity	%	93.0
	2899519	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	87.0	CHEMBL5284	Homo sapiens	Activity	%	87.0
	2899520	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	2899521	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	87.0	CHEMBL5284	Homo sapiens	Activity	%	87.0
	2899522	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	72.0	CHEMBL5284	Homo sapiens	Activity	%	72.0
	2899523	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	76.0	CHEMBL5284	Homo sapiens	Activity	%	76.0
	2899524	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	96.0	CHEMBL5284	Homo sapiens	Activity	%	96.0
	2899525	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	88.0	CHEMBL5284	Homo sapiens	Activity	%	88.0
	2899526	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	108.0	CHEMBL5284	Homo sapiens	Activity	%	108.0
	2899527	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	69.0	CHEMBL5284	Homo sapiens	Activity	%	69.0
	2899528	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	103.0	CHEMBL5284	Homo sapiens	Activity	%	103.0
	2899529	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	92.0	CHEMBL5284	Homo sapiens	Activity	%	92.0
	2899530	CHEMBL1061996	Percentage CaMKKbeta activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	108.0	CHEMBL5284	Homo sapiens	Activity	%	108.0
	2899531	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	88.0	CHEMBL5284	Homo sapiens	Activity	%	88.0
	2899532	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	84.0	CHEMBL5284	Homo sapiens	Activity	%	84.0
	2899533	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	79.0	CHEMBL5284	Homo sapiens	Activity	%	79.0
	2899534	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	63.0	CHEMBL5284	Homo sapiens	Activity	%	63.0
	2899535	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	86.0	CHEMBL5284	Homo sapiens	Activity	%	86.0
	2899536	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	61.0	CHEMBL5284	Homo sapiens	Activity	%	61.0
	2899537	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	90.0	CHEMBL5284	Homo sapiens	Activity	%	90.0
	2899538	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	99.0	CHEMBL5284	Homo sapiens	Activity	%	99.0
	2899539	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	86.0	CHEMBL5284	Homo sapiens	Activity	%	86.0
	2899540	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
	2899541	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
	2899542	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	68.0	CHEMBL5284	Homo sapiens	Activity	%	68.0
	2899543	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	61.0	CHEMBL5284	Homo sapiens	Activity	%	61.0
Antagonist	2899544	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	8.0	CHEMBL5284	Homo sapiens	Activity	%	8.0
Antagonist	2899545	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	41.0	CHEMBL5284	Homo sapiens	Activity	%	41.0
	2899546	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	91.0	CHEMBL5284	Homo sapiens	Activity	%	91.0
	2899547	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	81.0	CHEMBL5284	Homo sapiens	Activity	%	81.0
	2899548	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	90.0	CHEMBL5284	Homo sapiens	Activity	%	90.0
	2899549	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	93.0	CHEMBL5284	Homo sapiens	Activity	%	93.0
	2899550	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	89.0	CHEMBL5284	Homo sapiens	Activity	%	89.0
	2899551	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	63.0	CHEMBL5284	Homo sapiens	Activity	%	63.0
	2899552	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	102.0	CHEMBL5284	Homo sapiens	Activity	%	102.0
	2899553	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	79.0	CHEMBL5284	Homo sapiens	Activity	%	79.0
	2899554	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	65.0	CHEMBL5284	Homo sapiens	Activity	%	65.0
	2899555	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	90.0	CHEMBL5284	Homo sapiens	Activity	%	90.0
	2899556	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	89.0	CHEMBL5284	Homo sapiens	Activity	%	89.0
	2899557	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	103.0	CHEMBL5284	Homo sapiens	Activity	%	103.0
	2899558	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	83.0	CHEMBL5284	Homo sapiens	Activity	%	83.0
Antagonist	2899559	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	13.0	CHEMBL5284	Homo sapiens	Activity	%	13.0
Antagonist	2899560	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	32.0	CHEMBL5284	Homo sapiens	Activity	%	32.0
	2899561	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	94.0	CHEMBL5284	Homo sapiens	Activity	%	94.0
	2899562	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	138.0	CHEMBL5284	Homo sapiens	Activity	%	138.0
	2899563	CHEMBL1052080	Percentage CaMKKbeta activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	96.0	CHEMBL5284	Homo sapiens	Activity	%	96.0
	2899564	CHEMBL1061951	Percentage CaMKKbeta activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	86.0	CHEMBL5284	Homo sapiens	Activity	%	86.0
	2899565	CHEMBL1061951	Percentage CaMKKbeta activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	86.0	CHEMBL5284	Homo sapiens	Activity	%	86.0
	2899566	CHEMBL1061997	Percentage CaMKKbeta activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	82.0	CHEMBL5284	Homo sapiens	Activity	%	82.0
Antagonist	2899567	CHEMBL1062896	Percentage CaMKKbeta activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	49.0	CHEMBL5284	Homo sapiens	Activity	%	49.0
	2901247	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901248	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901249	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	220.0	CHEMBL5284	Homo sapiens	Kd	nM	220.0
	2901250	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901251	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901252	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901253	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901254	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901255	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901256	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901257	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901258	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901259	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2500.0	CHEMBL5284	Homo sapiens	Kd	nM	2500.0
	2901260	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901261	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	430.0	CHEMBL5284	Homo sapiens	Kd	nM	430.0
	2901262	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901263	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901264	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901265	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901266	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	2600.0	CHEMBL5284	Homo sapiens	Kd	nM	2600.0
	2901267	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901268	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2400.0	CHEMBL5284	Homo sapiens	Kd	nM	2400.0
	2901269	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901270	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901271	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901272	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	73.0	CHEMBL5284	Homo sapiens	Kd	nM	73.0
	2901273	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901274	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901275	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901276	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901277	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901278	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901279	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.16	CHEMBL5284	Homo sapiens	Kd	nM	0.16
	2901280	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2500.0	CHEMBL5284	Homo sapiens	Kd	nM	2500.0
	2901281	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1500.0	CHEMBL5284	Homo sapiens	Kd	nM	1500.0
	2901282	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901283	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2901284	CHEMBL1063793	Binding constant for CAMKK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	2921412	CHEMBL1052880	Inhibition of CAMKK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	98.0	CHEMBL5284	Homo sapiens	Activity	%	98.0
	2924785	CHEMBL1056869	Inhibition of CAMKKbeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	87.0	CHEMBL5284	Homo sapiens	Activity	%	87.0
	2924786	CHEMBL1056869	Inhibition of CAMKKbeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	93.0	CHEMBL5284	Homo sapiens	Activity	%	93.0
	2924787	CHEMBL1056869	Inhibition of CAMKKbeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	102.0	CHEMBL5284	Homo sapiens	Activity	%	102.0
	2924788	CHEMBL1056869	Inhibition of CAMKKbeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	56.0	CHEMBL5284	Homo sapiens	Activity	%	56.0
	2926215	CHEMBL1050227	Inhibition of CAMKKbeta assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	101.0	CHEMBL5284	Homo sapiens	Activity	%	101.0
	2928401	CHEMBL1060299	Inhibition of CAMKKbeta assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	104.0	CHEMBL5284	Homo sapiens	Activity	%	104.0
	2999009	CHEMBL1041981	Inhibition of CAMKKbeta assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	99.0	CHEMBL5284	Homo sapiens	Activity	%	99.0
	2999799	CHEMBL1041981	Inhibition of CAMKKbeta assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	2999874	CHEMBL1049876	Inhibition of CAMKKbeta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	88.0	CHEMBL5284	Homo sapiens	Activity	%	88.0
	2999950	CHEMBL1049876	Inhibition of CAMKKbeta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	92.0	CHEMBL5284	Homo sapiens	Activity	%	92.0
	3052545	CHEMBL1050410	Residual activity of CAMKK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL5284	Homo sapiens	Residual activity	%	90.0
	3052797	CHEMBL1047823	Residual activity of CAMKK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	112.0	CHEMBL5284	Homo sapiens	Residual activity	%	112.0
	3054106	CHEMBL1066624	Residual activity of CAMKK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL5284	Homo sapiens	Residual activity	%	86.0
	3055393	CHEMBL1050410	Residual activity of CAMKK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	91.0	CHEMBL5284	Homo sapiens	Residual activity	%	91.0
	3055645	CHEMBL1047823	Residual activity of CAMKK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	109.0	CHEMBL5284	Homo sapiens	Residual activity	%	109.0
	3056950	CHEMBL1066624	Residual activity of CAMKK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	91.0	CHEMBL5284	Homo sapiens	Residual activity	%	91.0
	3058270	CHEMBL1050410	Residual activity of CAMKK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	85.0	CHEMBL5284	Homo sapiens	Residual activity	%	85.0
	3058522	CHEMBL1047823	Residual activity of CAMKK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL5284	Homo sapiens	Residual activity	%	97.0
	3072868	CHEMBL1066624	Residual activity of CAMKK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	84.0	CHEMBL5284	Homo sapiens	Residual activity	%	84.0
	3260070	CHEMBL1104321	Inhibition of CAMKKbeta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	74.0	CHEMBL5284	Homo sapiens	Activity	%	74.0
	3261403	CHEMBL1104321	Inhibition of CAMKKbeta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	66.0	CHEMBL5284	Homo sapiens	Activity	%	66.0
	3331857	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3333272	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3334677	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3336097	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3337477	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3337725	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3339057	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3340359	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3340625	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3342041	CHEMBL1168816	Inhibition of CAMKK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	3358484	CHEMBL1174098	Inhibition of CAMKK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	7.8	CHEMBL5284	Homo sapiens	INH	%	7.8
	3358926	CHEMBL1174098	Inhibition of CAMKK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	27.0	CHEMBL5284	Homo sapiens	INH	%	27.0
	3445056	CHEMBL1244754	Binding affinity to CAMKK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	15.0	CHEMBL5284	Homo sapiens	Kd	nM	15.0
	3448366	CHEMBL1244754	Binding affinity to CAMKK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	3448893	CHEMBL1244754	Binding affinity to CAMKK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	73.0	CHEMBL5284	Homo sapiens	Kd	nM	73.0
	3449125	CHEMBL1244754	Binding affinity to CAMKK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	790.0	CHEMBL5284	Homo sapiens	Kd	nM	790.0
	3449405	CHEMBL1244754	Binding affinity to CAMKK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1500.0	CHEMBL5284	Homo sapiens	Kd	nM	1500.0
	3449590	CHEMBL1244754	Binding affinity to CAMKK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	3450018	CHEMBL1244754	Binding affinity to CAMKK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	uM	10.0
	5123792	CHEMBL1649032	Inhibition of CAMKK2 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	97.0	CHEMBL5284	Homo sapiens	INH	%	97.0
	5133682	CHEMBL1648730	Inhibition of CAMKKbeta assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	91.0	CHEMBL5284	Homo sapiens	Activity	%	91.0
	5133777	CHEMBL1648730	Inhibition of CAMKKbeta assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	92.0	CHEMBL5284	Homo sapiens	Activity	%	92.0
	5133894	CHEMBL1648730	Inhibition of CAMKKbeta assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	87.0	CHEMBL5284	Homo sapiens	Activity	%	87.0
	5191383	CHEMBL1664048	Inhibition of CAMKKbeta at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	48.0	CHEMBL5284	Homo sapiens	INH	%	48.0
	5191384	CHEMBL1664048	Inhibition of CAMKKbeta at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	91.0	CHEMBL5284	Homo sapiens	INH	%	91.0
	6167595	CHEMBL1769238	Binding affinity to human CAMKK2 isoleucine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	6167619	CHEMBL1768479	Binding affinity to human CAMKK2 isoleucine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	2.1	CHEMBL5284	Homo sapiens	Activity	%	2.1
	6273811	CHEMBL1806149	Inhibition of CAMKKbeta assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	23.0	CHEMBL5284	Homo sapiens	Activity	%	23.0
	6274515	CHEMBL1806278	Inhibition of CAMKKbeta at 0.1 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	6274565	CHEMBL1806284	Inhibition of CAMKKbeta	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	IC50	nM	2450.0	CHEMBL5284	Homo sapiens	IC50	nmol/L	2450.0
	6339932	CHEMBL1826615	Activity of CAMKK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	76.0	CHEMBL5284	Homo sapiens	Activity	%	76.0
	6352195	CHEMBL1825732	Inhibition of CAMKKbeta assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	52.0	CHEMBL5284	Homo sapiens	Activity	%	52.0
	7567459	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7567947	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7568415	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7568847	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2500.0	CHEMBL5284	Homo sapiens	Kd	nM	2500.0
	7569450	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7569922	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7570385	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	73.0	CHEMBL5284	Homo sapiens	Kd	nM	73.0
	7570812	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1500.0	CHEMBL5284	Homo sapiens	Kd	nM	1500.0
	7570966	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7571423	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1500.0	CHEMBL5284	Homo sapiens	Kd	nM	1500.0
	7571899	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7572362	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7572778	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	11.0	CHEMBL5284	Homo sapiens	Kd	nM	11.0
	7572947	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	23.0	CHEMBL5284	Homo sapiens	Kd	nM	23.0
	7573404	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7573880	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7574349	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	73.0	CHEMBL5284	Homo sapiens	Kd	nM	73.0
	7574757	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7574925	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	920.0	CHEMBL5284	Homo sapiens	Kd	nM	920.0
	7575386	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7575857	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7576899	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7577358	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	4400.0	CHEMBL5284	Homo sapiens	Kd	nM	4400.0
	7577864	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7578269	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	4000.0	CHEMBL5284	Homo sapiens	Kd	nM	4000.0
	7578907	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	740.0	CHEMBL5284	Homo sapiens	Kd	nM	740.0
	7579281	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7579731	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	430.0	CHEMBL5284	Homo sapiens	Kd	nM	430.0
	7579763	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	470.0	CHEMBL5284	Homo sapiens	Kd	nM	470.0
	7580232	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	3800.0	CHEMBL5284	Homo sapiens	Kd	nM	3800.0
	7580635	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7581265	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7581650	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7582124	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7582588	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7582988	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7584011	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7584482	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	6700.0	CHEMBL5284	Homo sapiens	Kd	nM	6700.0
	7584944	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7585348	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7585499	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7585907	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7586353	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7586824	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2400.0	CHEMBL5284	Homo sapiens	Kd	nM	2400.0
	7587278	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	1400.0	CHEMBL5284	Homo sapiens	Kd	nM	1400.0
	7587460	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7587879	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7588332	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7588803	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7589254	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7589425	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1500.0	CHEMBL5284	Homo sapiens	Kd	nM	1500.0
	7589849	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	15.0	CHEMBL5284	Homo sapiens	Kd	nM	15.0
	7590316	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7590790	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7591398	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7591820	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7592292	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7592765	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7592776	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7593365	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	220.0	CHEMBL5284	Homo sapiens	Kd	nM	220.0
	7593800	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7594272	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7594755	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	780.0	CHEMBL5284	Homo sapiens	Kd	nM	780.0
	7595333	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	2400.0	CHEMBL5284	Homo sapiens	Kd	nM	2400.0
	7595777	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7596280	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7596727	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7597305	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7597758	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7597789	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7598259	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5284	Homo sapiens	Kd	nM	10000.0
	7598701	CHEMBL1908757	Binding constant for CAMKK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.16	CHEMBL5284	Homo sapiens	Kd	nM	0.16
	7969700	CHEMBL1930956	Inhibition of CAMKKbeta assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	89.0	CHEMBL5284	Homo sapiens	Activity	%	89.0
	7996682	CHEMBL1944013	Inhibition of CAMKK2 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	97.0	CHEMBL5284	Homo sapiens	INH	%	97.0
	8003556	CHEMBL1942479	Inhibition of human CaMKK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5284	Homo sapiens	INH	%	35.0
	8003557	CHEMBL1942479	Inhibition of human CaMKK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5284	Homo sapiens	INH	%	35.0
	8003558	CHEMBL1942479	Inhibition of human CaMKK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5284	Homo sapiens	INH	%	35.0
	8003559	CHEMBL1942479	Inhibition of human CaMKK2 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5284	Homo sapiens	INH	%	35.0
	8047094	CHEMBL1958829	Inhibition of CAMKK2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
inactive	9572048	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572049	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572050	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	63.1	CHEMBL5284	Homo sapiens	pKi		7.2
inactive	9572051	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572052	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572053	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1.259	CHEMBL5284	Homo sapiens	pKi		8.9
inactive	9572054	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572055	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	316.23	CHEMBL5284	Homo sapiens	pKi		6.5
active	9572056	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	158.49	CHEMBL5284	Homo sapiens	pKi		6.8
inactive	9572057	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572058	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572059	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572060	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	630.96	CHEMBL5284	Homo sapiens	pKi		6.2
inactive	9572061	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572062	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	794.33	CHEMBL5284	Homo sapiens	pKi		6.1
inactive	9572063	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572064	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	63.1	CHEMBL5284	Homo sapiens	pKi		7.2
inactive	9572065	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572066	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572067	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572068	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572069	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572070	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572071	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572072	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572073	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572074	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572075	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572076	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572077	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572078	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	158.49	CHEMBL5284	Homo sapiens	pKi		6.8
inactive	9572079	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
inactive	9572080	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572081	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	0.1995	CHEMBL5284	Homo sapiens	pKi		9.7
inactive	9572082	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572083	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	1.259	CHEMBL5284	Homo sapiens	pKi		8.9
inactive	9572084	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	2511.89	CHEMBL5284	Homo sapiens	pKi		5.6
active	9572085	CHEMBL1963755	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMKK2	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	=	Ki	nM	1258.93	CHEMBL5284	Homo sapiens	pKi		5.9
	10839539	CHEMBL2015930	Inhibition of CAMKKb assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	5.0	CHEMBL5284	Homo sapiens	Activity	%	5.0
	10839556	CHEMBL2015838	Inhibition of CAMKKb assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	9.0	CHEMBL5284	Homo sapiens	Activity	%	9.0
	12060547	CHEMBL2154884	Binding affinity to CAMKK2	B	Nc1nc2c(-c3ccccn3)nccc2[nH]1		CHEMBL2153264	=	Kd	nM	40000.0	CHEMBL5284	Homo sapiens	Kd	nM	40000.0
	12170835	CHEMBL2212702	Inhibition of CAMKKb assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
	12172136	CHEMBL2214392	Inhibition of CAMKKb assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	96.0	CHEMBL5284	Homo sapiens	Activity	%	96.0
	12173707	CHEMBL2209343	Inhibition of CAMKK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	12183914	CHEMBL2211051	Inhibition of CAMKK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	pIC50		5.0
	12673083	CHEMBL2345627	Inhibition of recombinant CAMKKbeta (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	13.0	CHEMBL5284	Homo sapiens	Activity	%	13.0
	12673084	CHEMBL2345627	Inhibition of recombinant CAMKKbeta (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	17.0	CHEMBL5284	Homo sapiens	Activity	%	17.0
	12730914	CHEMBL2349842	Inhibition of CAMKK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	65.0	CHEMBL5284	Homo sapiens	Activity	%	65.0
	13375926	CHEMBL2405938	Inhibition of CAMKK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL5284	Homo sapiens	INH	%	3.0
	13442388	CHEMBL2428010	Competitive binding affinity to CAMKK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	13443081	CHEMBL2427509	Inhibition of CAMKKbeta (unknown origin) at 1 uM relative to control	B	COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL2426288	>	Inhibition	%	75.0	CHEMBL5284	Homo sapiens	INH	%	75.0
	13445523	CHEMBL2428010	Competitive binding affinity to CAMKK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	84.0	CHEMBL5284	Homo sapiens	INH	%	84.0
	13448578	CHEMBL2428010	Competitive binding affinity to CAMKK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	65.0	CHEMBL5284	Homo sapiens	INH	%	65.0
	13448714	CHEMBL2428010	Competitive binding affinity to CAMKK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	75.0	CHEMBL5284	Homo sapiens	INH	%	75.0
	13451509	CHEMBL2428010	Competitive binding affinity to CAMKK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	86.0	CHEMBL5284	Homo sapiens	INH	%	86.0
	13454694	CHEMBL2428010	Competitive binding affinity to CAMKK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	72.0	CHEMBL5284	Homo sapiens	INH	%	72.0
	13490915	CHEMBL2446680	Inhibition of CAMKK2 (unknown origin)	B	CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441273	=	IC50	nM	199.53	CHEMBL5284	Homo sapiens	pIC50		6.7
	14648088	CHEMBL3266645	Inhibition of human CAMKK-beta at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	14648089	CHEMBL3266645	Inhibition of human CAMKK-beta at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	15072462	CHEMBL3380112	Inhibition of CAMKKB (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	85.0	CHEMBL5284	Homo sapiens	Activity	%	85.0
	15073013	CHEMBL3389031	Inhibition of CAMKKbeta (unknown origin) at 1 uM relative to control	B	COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL2426288	=	Inhibition	%	94.0	CHEMBL5284	Homo sapiens	INH	%	94.0
	15073066	CHEMBL3389031	Inhibition of CAMKKbeta (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C)CC1		CHEMBL2426277	=	Inhibition	%	92.0	CHEMBL5284	Homo sapiens	INH	%	92.0
	15251860	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	36.0	CHEMBL5284	Homo sapiens	Activity	%	36.0
	15251937	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	26.0	CHEMBL5284	Homo sapiens	Activity	%	26.0
	15252039	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	81.0	CHEMBL5284	Homo sapiens	Activity	%	81.0
	15252684	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	96.0	CHEMBL5284	Homo sapiens	Activity	%	96.0
	15252786	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	73.0	CHEMBL5284	Homo sapiens	Activity	%	73.0
	15252888	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	87.0	CHEMBL5284	Homo sapiens	Activity	%	87.0
	15253562	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	89.0	CHEMBL5284	Homo sapiens	Activity	%	89.0
	15253664	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	84.0	CHEMBL5284	Homo sapiens	Activity	%	84.0
	15253766	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	52.0	CHEMBL5284	Homo sapiens	Activity	%	52.0
	15254432	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	72.0	CHEMBL5284	Homo sapiens	Activity	%	72.0
	15254534	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	74.0	CHEMBL5284	Homo sapiens	Activity	%	74.0
	15254636	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	59.0	CHEMBL5284	Homo sapiens	Activity	%	59.0
	15255327	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	49.0	CHEMBL5284	Homo sapiens	Activity	%	49.0
	15255429	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	74.0	CHEMBL5284	Homo sapiens	Activity	%	74.0
	15255532	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	57.0	CHEMBL5284	Homo sapiens	Activity	%	57.0
	15256263	CHEMBL3428221	Inhibition of CAMKK-beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	65.0	CHEMBL5284	Homo sapiens	Activity	%	65.0
	15258338	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	7.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	7.9
	15258398	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.1
	15258458	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.4
	15258518	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	2.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.0
	15258578	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	1.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.4
	15258638	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	2.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.4
	15258698	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	3.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.8
	15258758	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258818	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.8
	15258878	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.5
	15258938	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	2.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.8
	15258998	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	3.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.7
	15259058	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	2.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.3
	15259118	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	5.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	5.9
	15259178	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	8.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	8.6
	15259238	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	3.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.5
	15259298	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.8
	15259358	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259418	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.2
	15259478	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.7
	15259538	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.1
	15259598	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	-0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.6
	15259658	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	1.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.6
	15259718	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	6.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	6.8
	15259778	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.7
	15259838	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	1.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.3
	15259898	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259958	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.6
	15260018	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	1.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.2
	15260078	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.3
	15260138	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	1.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.6
	15260198	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	3.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.0
	15260258	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	1.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.7
	15260318	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	1.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.9
	15260378	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	1.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.7
	15260438	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-2.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-2.4
	15260498	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	3.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.6
	15260558	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	2.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.0
	15260618	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	1.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.8
	15260678	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	3.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.3
	15260738	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.4
	15260798	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	3.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.8
	15260858	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	4.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	4.7
	15260918	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.6
	15260978	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.5
	15261038	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261098	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.7
	15261181	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	-0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.5
	15261241	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	-0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.5
	15261301	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	-1.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.0
	15261361	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	2.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.7
	15261416	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	1.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.4
	15261476	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.9
	15261536	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	6.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	6.3
	15261596	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-1.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.6
	15261669	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	1.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.4
	15261729	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.9
	15261789	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	3.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.0
	15261849	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.3
	15261905	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.4
	15261965	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	1.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.0
	15262025	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	-0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262085	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	0.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.0
	15262158	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.7
	15262218	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	1.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.0
	15262278	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	2.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.0
	15262338	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.8
	15262398	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.6
	15262458	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.5
	15262518	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	3.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.5
	15262578	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	2.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.0
	15262638	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	1.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.0
	15262698	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	1.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.0
	15262758	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.5
	15262818	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	2.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.3
	15262878	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	1.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.8
	15262938	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.3
	15262998	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	2.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.0
	15263058	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	2.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.5
	15263118	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	-0.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.7
	15263178	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.2
	15263238	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.5
	15263298	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263358	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263394	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	6.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	6.3
	15263454	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	-0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.8
	15263509	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	2.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.4
	15263569	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	1.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.3
	15263629	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.6
	15263689	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	1.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.3
	15263763	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263823	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	1.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.4
	15263883	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	2.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.0
	15263943	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	2.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.8
	15263997	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	2.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.3
	15264057	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-2.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-2.1
	15264117	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.6
	15264177	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	-0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264250	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	3.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.1
	15264310	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	-0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.8
	15264370	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	6.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	6.1
	15264430	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	3.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	3.4
	15264486	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	4.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	4.3
	15264546	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	4.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	4.2
	15264606	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.0
	15264666	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.3
	15264738	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-1.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.4
	15264798	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	-0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.8
	15264858	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	1.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.3
	15264918	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	2.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.8
	15264974	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265034	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-4.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-4.7
	15265094	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.0
	15265154	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	2.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.6
	15265214	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265227	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	2.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.3
	15265287	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	-0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265347	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.2
	15265407	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	1.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.2
	15265523	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.4
	15265583	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	-0.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265643	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265703	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	7.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	7.6
	15265715	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	-0.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265775	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.3
	15265835	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.1
	15265895	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265955	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	4.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	4.4
	15266012	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.5
	15266072	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	-0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.2
	15266132	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	6.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	6.9
	15266192	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	4.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	4.9
	15266264	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-2.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-2.5
	15266324	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.6
	15266384	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	4.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	4.7
	15266444	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	5.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	5.5
	15266499	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	-1.7	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.7
	15266559	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	2.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.6
	15266619	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	-0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266679	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	-0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.4
	15266752	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.4	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.4
	15266812	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	2.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.8
	15266872	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	1.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.8
	15266932	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.2
	15266987	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	0.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.1
	15267047	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	-1.3	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.3
	15267107	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	-0.8	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.8
	15267167	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	18.6	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	18.6
	15267240	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	2.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	2.5
	15267300	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	1.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	1.1
	15267360	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	-0.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267420	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.0	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.0
	15267475	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-1.2	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.2
	15267535	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.9	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	0.9
	15267595	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-1.5	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.5
	15267655	CHEMBL3430797	Delta TM value showing the stabilisation of CAMKK2 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-1.1	CHEMBL5284	Homo sapiens	Thermal melting change	degrees C	-1.1
	15666941	CHEMBL3603235	Inhibition of CAMKK2 (unknown origin) assessed as residual enzyme activity at 1 uM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL3601223	=	Activity	%	4.2	CHEMBL5284	Homo sapiens	Activity	%	4.2
	15686169	CHEMBL3606875	Inhibition of CAMKKB (unknown origin) at 2 uM by radioactive filter-binding assay	B	NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I		CHEMBL3605056	>=	Inhibition	%	80.0	CHEMBL5284	Homo sapiens	INH	%	80.0
	15686191	CHEMBL3606982	Inhibition of CAMKKB (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL5284	Homo sapiens	INH	%	80.0
	15756080	CHEMBL3632291	Inhibition of CAMKK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-1.4	CHEMBL5284	Homo sapiens	INH	%	-1.4
	15757060	CHEMBL3632291	Inhibition of CAMKK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	54.25	CHEMBL5284	Homo sapiens	INH	%	54.25
	15758642	CHEMBL3632291	Inhibition of CAMKK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-15.62	CHEMBL5284	Homo sapiens	INH	%	-15.62
	16425361	CHEMBL3751231	Inhibition of CAMKK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	8.2	CHEMBL5284	Homo sapiens	INH	%	8.2
	16431759	CHEMBL3748651	Inhibition of human CAMKK2 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	IC50	uM	10.0
	16450776	CHEMBL3762162	Inhibition of CAMKK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	1.8	CHEMBL5284	Homo sapiens	INH	%	1.8
Not Active	16496861	CHEMBL3776409	Inhibition of human CAMKKB at 1 uM	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
	16507371	CHEMBL3777413	Inhibition of recombinant CAMKKB (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	49.0	CHEMBL5284	Homo sapiens	Activity	%	49.0
	16568749	CHEMBL3804022	Inhibition of full length recombinant human CaMKK2 expressed in insect Sf21 cells in presence of 2 uM CaM/[gamma32P]ATP by liquid scintillation counting analysis	B	COc1cccc(CN(CCN(CCN(C)C)Cc2ccccc2)Cc2ccccc2)c1		CHEMBL3798296	=	IC50	nM	40400.0	CHEMBL5284	Homo sapiens	IC50	uM	40.4
	16611819	CHEMBL3816732	Inhibition of human CAMKKb (1 to 541 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-86.0	CHEMBL5284	Homo sapiens	Activity	%	-86.0
	16611820	CHEMBL3816732	Inhibition of human CAMKKb (1 to 541 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-58.0	CHEMBL5284	Homo sapiens	Activity	%	-58.0
	16611821	CHEMBL3816732	Inhibition of human CAMKKb (1 to 541 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-2.0	CHEMBL5284	Homo sapiens	Activity	%	-2.0
	16611822	CHEMBL3816732	Inhibition of human CAMKKb (1 to 541 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-31.0	CHEMBL5284	Homo sapiens	Activity	%	-31.0
	16614409	CHEMBL3817229	Inhibition of human CAMKK2 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	14.0	CHEMBL5284	Homo sapiens	INH	%	14.0
	16628484	CHEMBL3820296	Inhibition of human recombinant full-length CAMKKbeta expressed in Escherichia coli at 1 uM using AKPKGNKDYHLQTCCGSLAYRRR as substrate	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL5284	Homo sapiens	INH	%	80.0
	16654155	CHEMBL3829168	Inhibition of human CAMKKbeta (1 to 541 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	18.0	CHEMBL5284	Homo sapiens	Activity	%	18.0
Inactive	17887167	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887168	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887169	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887170	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887171	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887172	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887173	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887174	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887175	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887176	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887177	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887178	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887179	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	2189.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2189.0
Inactive	17887180	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887181	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887182	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887183	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887184	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887185	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887186	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887187	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887188	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887189	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887190	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887191	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887192	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887193	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887194	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887195	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887196	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	2648.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2648.0
Inactive	17887197	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887198	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887199	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887200	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887201	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887202	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	2598.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2598.0
Active	17887203	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	2339.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2339.0
Inactive	17887204	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887205	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	258.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	258.0
Inactive	17887206	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887207	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887208	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887209	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887210	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887211	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887212	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887213	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887214	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Kd	nM	5429.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	5429.0
Inactive	17887215	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887216	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887217	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	35559.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	35559.0
Inactive	17887218	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887219	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887220	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887221	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887222	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887223	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887224	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887225	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887226	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887227	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887228	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887229	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887230	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887231	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887232	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887233	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887234	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887235	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887236	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	=	Kd	nM	195.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	195.0
Inactive	17887237	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887238	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887239	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887240	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2333.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2333.0
Active	17887241	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	3616.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	3616.0
Inactive	17887242	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887243	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887244	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887245	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1238.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	1238.0
Inactive	17887246	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887247	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887248	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887249	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887250	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887251	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887252	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887253	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887254	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887255	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887256	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887257	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887258	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887259	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887260	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	9130.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	9130.0
Inactive	17887261	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887262	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887263	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	135.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	135.0
Inactive	17887264	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887265	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887266	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887267	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887268	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887269	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887270	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	30.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30.0
Inactive	17887271	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887272	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887273	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887274	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887275	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887276	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887277	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887278	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887279	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887280	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887281	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887282	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887283	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887284	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887285	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887286	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887287	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887288	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887289	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887290	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887291	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887292	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887293	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887294	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887295	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887296	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887297	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1381.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	1381.0
Inactive	17887298	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887299	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887300	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887301	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1766.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	1766.0
Inactive	17887302	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887303	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887304	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887305	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887306	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887307	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887308	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887309	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887310	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887311	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887312	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887313	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887314	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887315	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887316	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1390.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	1390.0
Active	17887317	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2277.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2277.0
Inactive	17887318	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887319	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887320	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887321	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887322	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887323	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887324	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887325	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887326	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887327	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887328	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887329	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887330	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887331	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887332	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887333	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887334	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887335	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887336	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887337	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887338	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887339	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887340	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887341	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1379.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	1379.0
Inactive	17887342	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887343	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887344	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887345	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887346	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887347	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887348	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887349	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887350	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	52847.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	52847.0
Inactive	17887351	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887352	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887353	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887354	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887355	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887356	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887357	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887358	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887359	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887360	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887361	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887362	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887363	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	2862.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	2862.0
Inactive	17887364	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887365	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887366	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887367	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	521.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	521.0
Inactive	17887368	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887369	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887370	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887371	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887372	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887373	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887374	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887375	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887376	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887377	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887378	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887379	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887380	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887381	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887382	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	126.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	126.0
Inactive	17887383	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887384	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	=	Kd	nM	3633.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	3633.0
Inactive	17887385	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887386	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887387	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887388	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887389	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887390	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887391	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887392	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887393	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887394	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887395	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887396	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887397	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Active	17887398	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	7694.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	7694.0
Inactive	17887399	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887400	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887401	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887402	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887403	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887404	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887405	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887406	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887407	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887408	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887409	CHEMBL3991644	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5284	Homo sapiens	Kd apparent	nM	30000.0
	18031637	CHEMBL4007691	Inhibition of CAMKK2 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	1910.0	CHEMBL5284	Homo sapiens	IC50	uM	1.91
	18112100	CHEMBL4024294	Inhibition of recombinant human full length C-terminal 6His-tagged CaMKK2 expressed in baculovirus infected sf21 cells	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)nc2n1C1CCCC1		CHEMBL4063500	=	IC50	nM	53.0	CHEMBL5284	Homo sapiens	IC50	uM	0.053
	18114449	CHEMBL4025045	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	18135855	CHEMBL4029822	Inhibition of CAMKK2 (unknown origin) using NUAK2 peptide as substrate measured after 30 mins in presence of [gamma32P]ATP by liquid scintillation counting method	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4ccc(C(=O)O)cc43)c3ccccc3)cc2)CC1		CHEMBL4089284	=	Ki	nM	85.0	CHEMBL5284	Homo sapiens	Ki	nM	85.0
	18135859	CHEMBL4029822	Inhibition of CAMKK2 (unknown origin) using NUAK2 peptide as substrate measured after 30 mins in presence of [gamma32P]ATP by liquid scintillation counting method	B	COC(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)C(=O)N2		CHEMBL4062168	=	Ki	nM	31.0	CHEMBL5284	Homo sapiens	Ki	nM	31.0
	18135864	CHEMBL4029822	Inhibition of CAMKK2 (unknown origin) using NUAK2 peptide as substrate measured after 30 mins in presence of [gamma32P]ATP by liquid scintillation counting method	B	CN1CCN(CC(=O)N(C)c2ccc(N/C(=C3\C(=O)Nc4ccccc43)c3ccccc3)cc2)CC1		CHEMBL1908392	=	Ki	nM	15.0	CHEMBL5284	Homo sapiens	Ki	nM	15.0
	18143373	CHEMBL4031766	Inhibition of CAMKK2 in human HCT116 cell lysate after 1 hr by LC-MS/MS analysis relative to control	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	=	IC50	nM	680.0	CHEMBL5284	Homo sapiens	IC50	uM	0.68
	18143376	CHEMBL4031763	Binding affinity to CAMKK2 in human HCT116 cell lysate at 3 uM after 1 hr by LC-MS/MS analysis	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	>=	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	18153126	CHEMBL4034280	Inhibition of CaMKK2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	6.4	CHEMBL5284	Homo sapiens	INH	%	6.4
	18203569	CHEMBL4043856	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	99.0	CHEMBL5284	Homo sapiens	Activity	%	99.0
	18211630	CHEMBL4045653	Inhibition of CaMKK2 labeling at conserved Lys2 (DIKPSNLLVGEDGHIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-32.2	CHEMBL5284	Homo sapiens	INH	%	-32.2
	18211800	CHEMBL4045896	Inhibition of CaMKK2 labeling at conserved Lys2 (DIKPSNLLVGEDGHIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-39.1	CHEMBL5284	Homo sapiens	INH	%	-39.1
	18232169	CHEMBL4050337	Inhibition of human CAMKKb assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	81.0	CHEMBL5284	Homo sapiens	Activity	%	81.0
	18253495	CHEMBL4055031	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	83.0	CHEMBL5284	Homo sapiens	Activity	%	83.0
	18253496	CHEMBL4055031	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	64.0	CHEMBL5284	Homo sapiens	Activity	%	64.0
	18282032	CHEMBL4119987	Inhibition of recombinant full length GST-tagged human CAMKK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	1.5	CHEMBL5284	Homo sapiens	INH	%	1.5
	18282351	CHEMBL4119987	Inhibition of recombinant full length GST-tagged human CAMKK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	8.7	CHEMBL5284	Homo sapiens	INH	%	8.7
	18287186	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	IC50	nM	7.943	CHEMBL5284	Homo sapiens	pIC50		8.1
	18287187	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CC(C)Cc1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)ccc1C(=O)O		CHEMBL564555	=	IC50	nM	25.12	CHEMBL5284	Homo sapiens	pIC50		7.6
	18287188	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CC(C)c1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)ccc1C(=O)O		CHEMBL4127245	=	IC50	nM	3.981	CHEMBL5284	Homo sapiens	pIC50		8.4
	18287189	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CCc1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)ccc1C(=O)O		CHEMBL550110	=	IC50	nM	19.95	CHEMBL5284	Homo sapiens	pIC50		7.7
	18287190	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)ccc1C(=O)O		CHEMBL4128483	=	IC50	nM	50.12	CHEMBL5284	Homo sapiens	pIC50		7.3
	18287191	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1		CHEMBL550795	=	IC50	nM	199.53	CHEMBL5284	Homo sapiens	pIC50		6.7
	18287192	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	c1ccc(-c2cnc3[nH]cc(-c4ccc(-n5cnnn5)cc4)c3c2)cc1		CHEMBL4129709	=	IC50	nM	398.11	CHEMBL5284	Homo sapiens	pIC50		6.4
	18287193	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COC(=O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1		CHEMBL564824	=	IC50	nM	1258.93	CHEMBL5284	Homo sapiens	pIC50		5.9
	18287194	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4Oc4ccccc4)cc23)cc1		CHEMBL4126272	=	IC50	nM	50.12	CHEMBL5284	Homo sapiens	pIC50		7.3
	18287195	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4Oc4ccccc4)cc23)cc1		CHEMBL4130255	=	IC50	nM	100.0	CHEMBL5284	Homo sapiens	pIC50		7.0
	18287196	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4ccc(C(=O)O)cc4)c3c2)c1		CHEMBL546682	=	IC50	nM	125.89	CHEMBL5284	Homo sapiens	pIC50		6.9
	18287197	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CS(=O)(=O)c1cccc(-c2cnc3[nH]cc(-c4ccc(C(N)=O)cc4)c3c2)c1		CHEMBL4127706	=	IC50	nM	199.53	CHEMBL5284	Homo sapiens	pIC50		6.7
	18287198	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1-c1cnc2[nH]cc(-c3ccc(C(N)=O)c(C4CCCC4)c3)c2c1		CHEMBL4126332	=	IC50	nM	199.53	CHEMBL5284	Homo sapiens	pIC50		6.7
	18287266	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C#N)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4128540	=	IC50	nM	6.31	CHEMBL5284	Homo sapiens	pIC50		8.2
	18287267	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C#N)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4128459	=	IC50	nM	12.59	CHEMBL5284	Homo sapiens	pIC50		7.9
	18287268	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C#N)cc3)ccnc2[nH]1		CHEMBL4127076	=	IC50	nM	251.19	CHEMBL5284	Homo sapiens	pIC50		6.6
	18287269	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C#N)cc3)ccnc2[nH]1		CHEMBL4129941	=	IC50	nM	398.11	CHEMBL5284	Homo sapiens	pIC50		6.4
	18287270	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1-c1cc2c(-c3ccc(C(N)=O)c(C4CCCC4)c3)ccnc2[nH]1		CHEMBL4128577	=	IC50	nM	1.995	CHEMBL5284	Homo sapiens	pIC50		8.7
	18287271	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C(N)=O)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4126511	=	IC50	nM	7.943	CHEMBL5284	Homo sapiens	pIC50		8.1
	18287272	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C(N)=O)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4129791	=	IC50	nM	19.95	CHEMBL5284	Homo sapiens	pIC50		7.7
	18287273	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc(OCCN2CCOCC2)cc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4127479	=	IC50	nM	31.62	CHEMBL5284	Homo sapiens	pIC50		7.5
	18287274	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4126095	=	IC50	nM	1.585	CHEMBL5284	Homo sapiens	pIC50		8.8
	18287275	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1c(OCCN2CCOCC2)cccc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4128717	=	IC50	nM	15.85	CHEMBL5284	Homo sapiens	pIC50		7.8
	18287276	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4127330	=	IC50	nM	15.85	CHEMBL5284	Homo sapiens	pIC50		7.8
	18287277	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1cc(CN2CCOCC2)ccc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4130310	=	IC50	nM	25.12	CHEMBL5284	Homo sapiens	pIC50		7.6
	18287278	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1c(CN2CCOCC2)cccc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4128939	=	IC50	nM	12.59	CHEMBL5284	Homo sapiens	pIC50		7.9
	18287279	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1-c1cc2c(-c3ccc(C(N)=O)cc3)ccnc2[nH]1		CHEMBL4129362	=	IC50	nM	19.95	CHEMBL5284	Homo sapiens	pIC50		7.7
	18287280	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CS(=O)(=O)Nc1cccc(-c2cc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)c1		CHEMBL4127977	=	IC50	nM	12.59	CHEMBL5284	Homo sapiens	pIC50		7.9
	18287281	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CS(=O)(=O)Nc1ccc(-c2cc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)cc1		CHEMBL4128114	=	IC50	nM	12.59	CHEMBL5284	Homo sapiens	pIC50		7.9
	18287282	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CN(C)CCCNC(=O)c1cccc(-c2cc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)c1		CHEMBL4126740	=	IC50	nM	12.59	CHEMBL5284	Homo sapiens	pIC50		7.9
	18287283	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CN(C)CCCNC(=O)c1ccc(-c2cc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)cc1		CHEMBL4127140	=	IC50	nM	12.59	CHEMBL5284	Homo sapiens	pIC50		7.9
	18287284	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CN(C)Cc1cccc(-c2cc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)c1		CHEMBL4125774	=	IC50	nM	31.62	CHEMBL5284	Homo sapiens	pIC50		7.5
	18287285	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CN(C)Cc1ccc(-c2cc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)cc1		CHEMBL4125907	=	IC50	nM	25.12	CHEMBL5284	Homo sapiens	pIC50		7.6
	18287286	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1ncc(F)c(-c2ccc(C(=O)O)c(C(C)C)c2)n1		CHEMBL4129219	=	IC50	nM	7.943	CHEMBL5284	Homo sapiens	pIC50		8.1
	18287287	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1nccc(-c2ccc(C(=O)O)c(C(C)C)c2)n1		CHEMBL4129590	=	IC50	nM	1.995	CHEMBL5284	Homo sapiens	pIC50		8.7
	18287288	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1nccc(-c2ccc(C(=O)O)cc2)n1		CHEMBL4126300	=	IC50	nM	1584.89	CHEMBL5284	Homo sapiens	pIC50		5.8
	18287289	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1ncc(Cl)c(-c2ccc(C(N)=O)c(C(C)C)c2)n1		CHEMBL4126413	=	IC50	nM	1584.89	CHEMBL5284	Homo sapiens	pIC50		5.8
	18287290	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1ncc(F)c(-c2ccc(C(N)=O)c(C(C)C)c2)n1		CHEMBL4127797	=	IC50	nM	316.23	CHEMBL5284	Homo sapiens	pIC50		6.5
	18287291	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1nccc(-c2ccc(C(N)=O)c(C(C)C)c2)n1		CHEMBL4127640	=	IC50	nM	1584.89	CHEMBL5284	Homo sapiens	pIC50		5.8
	18287292	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccccc1Nc1nccc(-c2ccc(C(N)=O)cc2)n1		CHEMBL4129040	=	IC50	nM	1258.93	CHEMBL5284	Homo sapiens	pIC50		5.9
	18287293	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	COc1ccc(-c2ccccc2)cc1Nc1nccc(-c2ccc(C(N)=O)cc2)n1		CHEMBL4128625	=	IC50	nM	251.19	CHEMBL5284	Homo sapiens	pIC50		6.6
	18287294	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc(-c2ccccc2)cc1Nc1nccc(-c2ccc(C(N)=O)cc2)n1		CHEMBL4129991	=	IC50	nM	501.19	CHEMBL5284	Homo sapiens	pIC50		6.3
	18287295	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2ccnc(Nc3cc(-c4ccccc4)ccc3F)n2)cc1		CHEMBL4129843	=	IC50	nM	19.95	CHEMBL5284	Homo sapiens	pIC50		7.7
	18287296	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2ccnc(Nc3cccc(-c4ccccc4)c3)n2)cc1		CHEMBL4126566	=	IC50	nM	25.12	CHEMBL5284	Homo sapiens	pIC50		7.6
	18287297	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	O=C(O)c1ccc(-c2ccnc(Nc3cccc(-c4ccccc4)c3)n2)cc1		CHEMBL4127319	=	IC50	nM	100.0	CHEMBL5284	Homo sapiens	pIC50		7.0
	18287298	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CC(C)c1cc(-c2c[nH]c3nc(C#N)ccc23)ccc1C(N)=O		CHEMBL4125941	<=	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	pIC50		5.0
	18287299	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	N#Cc1ccc2c(-c3ccc(C(N)=O)c(C4CCCC4)c3)c[nH]c2n1		CHEMBL4127390	<=	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	pIC50		5.0
	18287300	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2c[nH]c3ncccc23)cc1		CHEMBL4126920	=	IC50	nM	398.11	CHEMBL5284	Homo sapiens	pIC50		6.4
	18287301	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)c[nH]c2n1		CHEMBL4129532	<=	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	pIC50		5.0
	18287302	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	Cc1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)c[nH]c2n1		CHEMBL4128151	=	IC50	nM	630.96	CHEMBL5284	Homo sapiens	pIC50		6.2
	18287303	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	N#Cc1ccc2c(-c3ccc(C(=O)O)cc3)c[nH]c2n1		CHEMBL4125834	<=	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	pIC50		5.0
	18287304	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CC(C)c1cc(-c2c[nH]c3nc(C#N)ccc23)ccc1C(=O)O		CHEMBL4129130	=	IC50	nM	794.33	CHEMBL5284	Homo sapiens	pIC50		6.1
	18287305	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	N#Cc1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)c[nH]c2n1		CHEMBL4127064	=	IC50	nM	15.85	CHEMBL5284	Homo sapiens	pIC50		7.8
	18287306	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	IC50	nM	31.62	CHEMBL5284	Homo sapiens	pIC50		7.5
	18287307	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1		CHEMBL4126604	=	IC50	nM	1995.26	CHEMBL5284	Homo sapiens	pIC50		5.7
	18287308	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4C(F)(F)F)cc23)cc1C1CCCC1		CHEMBL4127989	=	IC50	nM	3981.07	CHEMBL5284	Homo sapiens	pIC50		5.4
	18287309	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	N#CCc1ccccc1-c1cnc2[nH]cc(-c3ccc(C(N)=O)c(C4CCCC4)c3)c2c1		CHEMBL4130023	=	IC50	nM	2511.89	CHEMBL5284	Homo sapiens	pIC50		5.6
	18287310	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CN(C)c1ccccc1-c1cnc2[nH]cc(-c3ccc(C(N)=O)c(C4CCCC4)c3)c2c1		CHEMBL4126756	=	IC50	nM	3981.07	CHEMBL5284	Homo sapiens	pIC50		5.4
	18287311	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4OC(F)(F)F)cc23)cc1C1CCCC1		CHEMBL4128810	=	IC50	nM	1995.26	CHEMBL5284	Homo sapiens	pIC50		5.7
	18287312	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4Oc4ccccc4)cc23)cc1C1CCCC1		CHEMBL4130166	=	IC50	nM	1584.89	CHEMBL5284	Homo sapiens	pIC50		5.8
	18287313	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	CC(C)Oc1ccccc1-c1cnc2[nH]cc(-c3ccc(C(N)=O)c(C4CCCC4)c3)c2c1		CHEMBL4127557	=	IC50	nM	1584.89	CHEMBL5284	Homo sapiens	pIC50		5.8
	18287314	CHEMBL4121728	Inhibition of full-length human GST-tagged CAMKK2 using 5FAM-AKPKGNKDYHLQTCCGSLAYRRR-amide as substrate preincubated for 30 mins followed by substrate addition measured after 120 mins by fluorescence polarization assay	B	NC(=O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4O)cc23)cc1C1CCCC1		CHEMBL4128950	=	IC50	nM	125.89	CHEMBL5284	Homo sapiens	pIC50		6.9
	18440111	CHEMBL4156935	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	18443249	CHEMBL4157952	Inhibition of human CaMKKbeta assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	120.0	CHEMBL5284	Homo sapiens	Activity	%	120.0
	18449814	CHEMBL4178051	Inhibition of human CAMKKbeta (1 to 541 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	124.0	CHEMBL5284	Homo sapiens	Activity	%	124.0
	18462162	CHEMBL4180849	Inhibition of recombinant human full length GST-tagged CAMKKbeta expressed in Escherichia coli assessed as residual activity at 1 uM using AKPKGNKDYHLQTCCGSLAYRRR as substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	81.0	CHEMBL5284	Homo sapiens	Activity	%	81.0
	18463727	CHEMBL4181143	Inhibition of recombinant human full length N-terminal His6-tagged CaMKK2 expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	1.0	CHEMBL5284	Homo sapiens	INH	%	1.0
	18484551	CHEMBL4185714	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	89.0	CHEMBL5284	Homo sapiens	Activity	%	89.0
	18485070	CHEMBL4185714	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	92.0	CHEMBL5284	Homo sapiens	Activity	%	92.0
	18507868	CHEMBL4190898	Inhibition of recombinant full-length human CAMKK2 at 1 uM using calmodulin as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-4.0	CHEMBL5284	Homo sapiens	INH	%	-4.0
	18655621	CHEMBL4230614	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	91.0	CHEMBL5284	Homo sapiens	Activity	%	91.0
	18751700	CHEMBL4264203	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	18764500	CHEMBL4267069	Inhibition of human CAMKKb at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL5284	Homo sapiens	INH	%	70.0
	18764501	CHEMBL4267069	Inhibition of human CAMKKb at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL5284	Homo sapiens	INH	%	70.0
	18764502	CHEMBL4267069	Inhibition of human CAMKKb at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL5284	Homo sapiens	INH	%	70.0
	18782834	CHEMBL4270700	Inhibition of CAMKKbeta (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL5284	Homo sapiens	Activity	%	80.0
	18857873	CHEMBL4307719	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	69.0	CHEMBL5284	Homo sapiens	Activity	%	69.0
	18892570	CHEMBL4314745	Inhibition of recombinant full-length human CAMKk2 T85S mutant assessed as residual activity at 10 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	99.5	CHEMBL5284	Homo sapiens	Activity	%	99.5
	18919397	CHEMBL4322757	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CAMKK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr in presence of calmodulin by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	2.0	CHEMBL5284	Homo sapiens	Kd	nM	2.0
	18919585	CHEMBL4322757	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CAMKK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr in presence of calmodulin by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	6.0	CHEMBL5284	Homo sapiens	Kd	nM	6.0
	18937769	CHEMBL4327614	Inhibition of human CAMKK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	83.71	CHEMBL5284	Homo sapiens	Activity	%	83.71
	18937770	CHEMBL4327614	Inhibition of human CAMKK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	76.89	CHEMBL5284	Homo sapiens	Activity	%	76.89
	18938455	CHEMBL4327975	Inhibition of human CAMKK2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5284	Homo sapiens	Activity	%	65.0
	18938828	CHEMBL4328339	Inhibition of human CAMKK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	33.6	CHEMBL5284	Homo sapiens	IC50	10'-8M	3.36
	18953707	CHEMBL4331910	Inhibition of CAMKKb (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	46.0	CHEMBL5284	Homo sapiens	INH	%	46.0
	18953773	CHEMBL4331910	Inhibition of CAMKKb (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	36.0	CHEMBL5284	Homo sapiens	INH	%	36.0
	18953824	CHEMBL4331910	Inhibition of CAMKKb (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	72.0	CHEMBL5284	Homo sapiens	INH	%	72.0
	18953916	CHEMBL4331969	Inhibition of CAMKKb (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	1.0	CHEMBL5284	Homo sapiens	INH	%	1.0
	18953980	CHEMBL4331969	Inhibition of CAMKKb (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL5284	Homo sapiens	INH	%	0.0
	18954047	CHEMBL4331910	Inhibition of CAMKKb (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	6.0	CHEMBL5284	Homo sapiens	INH	%	6.0
	18958791	CHEMBL4333310	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	76.0	CHEMBL5284	Homo sapiens	Activity	%	76.0
	18964123	CHEMBL4334996	Inhibition of recombinant full length human CaMKK2 T85S mutant assessed as residual activity at 1 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL5284	Homo sapiens	Activity	%	92.0
	18964124	CHEMBL4334996	Inhibition of recombinant full length human CaMKK2 T85S mutant assessed as residual activity at 1 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	94.0	CHEMBL5284	Homo sapiens	Activity	%	94.0
	18971814	CHEMBL4336824	Inhibition of recombinant full length human CaMKK2 T85S mutant assessed as residual activity at 10 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	79.0	CHEMBL5284	Homo sapiens	Activity	%	79.0
Not Active	19039867	CHEMBL4351777	Inhibition of recombinant full-length human CAMKk2 T85S mutant at 10 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	19041040	CHEMBL4352301	Inhibition of human CAMKK2 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
	19059491	CHEMBL4357792	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	19090063	CHEMBL4365637	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	19091843	CHEMBL4366317	Inhibition of human CAMKK2 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	13.71	CHEMBL5284	Homo sapiens	INH	%	13.71
	19144679	CHEMBL4377695	Inhibition of recombinant full-length human CaMKK2 T85S mutant at 1 uM using calmodulin as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	88.0	CHEMBL5284	Homo sapiens	INH	%	88.0
	19147770	CHEMBL4379166	Inhibition of recombinant full length human CaMKK2 T85S mutant using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	IC50	uM	10.0
	19159319	CHEMBL4382423	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	1.6	CHEMBL5284	Homo sapiens	Activity	%	1.6
	19180973	CHEMBL4387183	Inhibition of tracer 236 binding to recombinant full length human GST-tagged CAMKK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	69.4	CHEMBL5284	Homo sapiens	INH	%	69.4
	19181199	CHEMBL4387183	Inhibition of tracer 236 binding to recombinant full length human GST-tagged CAMKK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	44.0	CHEMBL5284	Homo sapiens	INH	%	44.0
	19191688	CHEMBL4389142	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	92.0	CHEMBL5284	Homo sapiens	INH	%	92.0
	19191805	CHEMBL4389619	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	94.0	CHEMBL5284	Homo sapiens	INH	%	94.0
	19199977	CHEMBL4391245	Binding affinity to wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	18.0	CHEMBL5284	Homo sapiens	Activity	%	18.0
	19266340	CHEMBL4405290	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	20683716	CHEMBL4623653	Inhibition of human CAMKK2 using MBP as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4635411	=	Inhibition	%	33.72	CHEMBL5284	Homo sapiens	INH	%	33.72
	22391918	CHEMBL4667069	Inhibition of tracer 236 binding to recombinant human GST-tagged full length CAMKK2 expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.0	CHEMBL5284	Homo sapiens	INH	%	2.0
	22423773	CHEMBL4674462	Inhibition of human CAMKK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	64.73	CHEMBL5284	Homo sapiens	Activity	%	64.73
	22423774	CHEMBL4674462	Inhibition of human CAMKK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	57.63	CHEMBL5284	Homo sapiens	Activity	%	57.63
	22843205	CHEMBL4720233	Inhibition of CAMKK2 (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	IC50	nM	10000.0
	22843469	CHEMBL4720466	Inhibition of human CAMKK2 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	94.01	CHEMBL5284	Homo sapiens	Activity	%	94.01
	22843820	CHEMBL4720806	Inhibition of human CAMKK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.7	CHEMBL5284	Homo sapiens	IC50	10^-8M	1.57
	22844647	CHEMBL4721322	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	81.58	CHEMBL5284	Homo sapiens	Activity	%	81.58
	22851512	CHEMBL4723768	Binding affinity to human CAMKK2 assessed as displacement of immobilized ligand at 1 uM by KINOMEscan scanMAX assay relative to control	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	Inhibition	%	92.0	CHEMBL5284	Homo sapiens	INH	%	92.0
	22851522	CHEMBL4723778	Binding affinity to human CAMKK2 assessed as displacement of immobilized ligand by KINOMEscan scanMAX assay relative to control	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	Kd	nM	21.0	CHEMBL5284	Homo sapiens	Kd	nM	21.0
	22851532	CHEMBL4723788	Inhibition of human CAMKK2 in presence of ATP at Km level	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	>	IC50	nM	10000.0	CHEMBL5284	Homo sapiens	IC50	nM	10000.0
	22851537	CHEMBL4723793	Binding affinity to human CAMKK2 incubated for 2 hrs by nano-BRET assay based cellular target engagement assay	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	IC50	nM	2400.0	CHEMBL5284	Homo sapiens	IC50	nM	2400.0
Active	22946979	CHEMBL4765543	Inhibition of wild-type human CAMKK2 at 10 uM using myelin basic protein as substrate in presence of Ca2+ calmodulin and [gamma-33P]-ATP by radiometric hotspot kinase assay	B	CCCCCn1cc(-c2ccccc2OCc2ccccc2)nc1N.Cl		CHEMBL4795714		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
	22949048	CHEMBL4765735	Inhibition of human CAMKK2 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	56.0	CHEMBL5284	Homo sapiens	Activity	%	56.0
	22949049	CHEMBL4765735	Inhibition of human CAMKK2 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	73.0	CHEMBL5284	Homo sapiens	Activity	%	73.0
	22949050	CHEMBL4765735	Inhibition of human CAMKK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	76.0	CHEMBL5284	Homo sapiens	Activity	%	76.0
	22949051	CHEMBL4765735	Inhibition of human CAMKK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	83.0	CHEMBL5284	Homo sapiens	Activity	%	83.0
	22949052	CHEMBL4765735	Inhibition of human CAMKK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	53.0	CHEMBL5284	Homo sapiens	Activity	%	53.0
	22949053	CHEMBL4765735	Inhibition of human CAMKK2 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	62.0	CHEMBL5284	Homo sapiens	Activity	%	62.0
	22949054	CHEMBL4765736	Inhibition of human CAMKK2 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	50.0	CHEMBL5284	Homo sapiens	Activity	%	50.0
	22949055	CHEMBL4765736	Inhibition of human CAMKK2 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	25.0	CHEMBL5284	Homo sapiens	Activity	%	25.0
	22949056	CHEMBL4765736	Inhibition of human CAMKK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	30.0	CHEMBL5284	Homo sapiens	Activity	%	30.0
	22949057	CHEMBL4765736	Inhibition of human CAMKK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	31.0	CHEMBL5284	Homo sapiens	Activity	%	31.0
	22949058	CHEMBL4765736	Inhibition of human CAMKK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	19.0	CHEMBL5284	Homo sapiens	Activity	%	19.0
	22949059	CHEMBL4765736	Inhibition of human CAMKK2 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	25.0	CHEMBL5284	Homo sapiens	Activity	%	25.0
	22952778	CHEMBL4766715	Inhibition of recombinant full length human CaMKK2 assessed as residual activity at 10 uM using calmodulin as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	39.0	CHEMBL5284	Homo sapiens	Activity	%	39.0
	22955542	CHEMBL4767599	Inhibition of GST-tagged full length human CAMKK2 expressed in baculovirus expression system at 1 uM by Selectscreen kinase assay	B	COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12		CHEMBL4785582	=	Inhibition	%	77.0	CHEMBL5284	Homo sapiens	INH	%	77.0
	23120247	CHEMBL4804355	Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	74900.0	CHEMBL5284	Homo sapiens	IC50	uM	74.9
	23120248	CHEMBL4804355	Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	57000.0	CHEMBL5284	Homo sapiens	IC50	uM	57.0
	23120249	CHEMBL4804355	Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	88300.0	CHEMBL5284	Homo sapiens	IC50	uM	88.3
	23120250	CHEMBL4804355	Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	78500.0	CHEMBL5284	Homo sapiens	IC50	uM	78.5
	23120251	CHEMBL4804355	Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	85600.0	CHEMBL5284	Homo sapiens	IC50	uM	85.6
	23120252	CHEMBL4804355	Inhibition of CAMKK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	71800.0	CHEMBL5284	Homo sapiens	IC50	uM	71.8
	23121291	CHEMBL4804537	Inhibition of CAMKK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	23121292	CHEMBL4804537	Inhibition of CAMKK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	23121293	CHEMBL4804537	Inhibition of CAMKK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5284	Homo sapiens	INH	%	0.0
	23121294	CHEMBL4804537	Inhibition of CAMKK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL5284	Homo sapiens	INH	%	75.0
	23121295	CHEMBL4804537	Inhibition of CAMKK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	75.0	CHEMBL5284	Homo sapiens	INH	%	75.0
	23121296	CHEMBL4804537	Inhibition of CAMKK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL5284	Homo sapiens	INH	%	50.0
	23122477	CHEMBL4804828	Inhibition of human CAMKK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	82.0	CHEMBL5284	Homo sapiens	Activity	%	82.0
	23123172	CHEMBL4805416	Inhibition of human CAMKK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	23123717	CHEMBL4805961	Inhibition of DNA-tagged human CAMKK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	23124434	CHEMBL4806433	Inhibition of human CAMKK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	23124435	CHEMBL4806433	Inhibition of human CAMKK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	87.0	CHEMBL5284	Homo sapiens	Activity	%	87.0
	23127876	CHEMBL4807767	Inhibition of CAMKK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	23127877	CHEMBL4807767	Inhibition of CAMKK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	23127878	CHEMBL4807767	Inhibition of CAMKK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	23233849	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	Activity	%	3.0	CHEMBL5284	Homo sapiens	Activity	%	3.0
	23233850	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	Activity	%	0.0	CHEMBL5284	Homo sapiens	Activity	%	0.0
	23233851	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2cc(-c3ccccc3)cnc21		CHEMBL4859861	=	Activity	%	101.0	CHEMBL5284	Homo sapiens	Activity	%	101.0
	23233852	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2cccnc21		CHEMBL4853434	=	Activity	%	95.0	CHEMBL5284	Homo sapiens	Activity	%	95.0
	23233853	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4866741	=	Activity	%	7.0	CHEMBL5284	Homo sapiens	Activity	%	7.0
	23233854	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncccc23)cc1C1CCCC1		CHEMBL4861792	=	Activity	%	28.0	CHEMBL5284	Homo sapiens	Activity	%	28.0
	23233855	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4875005	=	Activity	%	3.0	CHEMBL5284	Homo sapiens	Activity	%	3.0
	23233856	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncccc23)cc1C1CCCC1		CHEMBL4845793	=	Activity	%	19.0	CHEMBL5284	Homo sapiens	Activity	%	19.0
	23233857	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4851892	=	Activity	%	9.0	CHEMBL5284	Homo sapiens	Activity	%	9.0
	23233858	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	=	Activity	%	5.0	CHEMBL5284	Homo sapiens	Activity	%	5.0
	23233859	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	Activity	%	4.0	CHEMBL5284	Homo sapiens	Activity	%	4.0
	23233860	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3cccnc23)cc1C1CCCC1		CHEMBL4863514	=	Activity	%	16.0	CHEMBL5284	Homo sapiens	Activity	%	16.0
	23233861	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2nnc3ccc(-c4ccccc4)nn23)cc1C1CCCC1		CHEMBL4855365	=	Activity	%	58.0	CHEMBL5284	Homo sapiens	Activity	%	58.0
	23233862	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2nnc3cccnn23)cc1C1CCCC1		CHEMBL4846152	=	Activity	%	83.0	CHEMBL5284	Homo sapiens	Activity	%	83.0
	23233863	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	Activity	%	6.0	CHEMBL5284	Homo sapiens	Activity	%	6.0
	23233864	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4873692	=	Activity	%	5.0	CHEMBL5284	Homo sapiens	Activity	%	5.0
	23233865	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	Activity	%	0.0	CHEMBL5284	Homo sapiens	Activity	%	0.0
	23233866	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]cnc23)cc1C1CCCC1		CHEMBL4863974	=	Activity	%	11.0	CHEMBL5284	Homo sapiens	Activity	%	11.0
	23233867	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3cc(-c4ccccc4)sc23)cc1C1CCCC1		CHEMBL4854650	=	Activity	%	0.0	CHEMBL5284	Homo sapiens	Activity	%	0.0
	23233868	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	Activity	%	0.0	CHEMBL5284	Homo sapiens	Activity	%	0.0
	23233869	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4857706	=	Activity	%	12.0	CHEMBL5284	Homo sapiens	Activity	%	12.0
	23233870	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sccc23)cc1C1CCCC1		CHEMBL4853274	=	Activity	%	2.0	CHEMBL5284	Homo sapiens	Activity	%	2.0
	23233871	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4877634	=	Activity	%	8.0	CHEMBL5284	Homo sapiens	Activity	%	8.0
	23233872	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523	=	Activity	%	3.0	CHEMBL5284	Homo sapiens	Activity	%	3.0
	23233873	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4849143	=	Activity	%	5.0	CHEMBL5284	Homo sapiens	Activity	%	5.0
	23233874	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccccc23)cc1C1CCCC1		CHEMBL4878827	=	Activity	%	10.0	CHEMBL5284	Homo sapiens	Activity	%	10.0
	23233875	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Cc1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2ccccc2n1		CHEMBL4865562	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	23233876	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccncc23)cc1C1CCCC1		CHEMBL4860464	=	Activity	%	86.0	CHEMBL5284	Homo sapiens	Activity	%	86.0
	23233877	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404	=	Activity	%	0.0	CHEMBL5284	Homo sapiens	Activity	%	0.0
	23233878	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(-c3ccccc3)n2)cc1C1CCCC1		CHEMBL4879358	=	Activity	%	26.0	CHEMBL5284	Homo sapiens	Activity	%	26.0
	23233879	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	=	Activity	%	0.0	CHEMBL5284	Homo sapiens	Activity	%	0.0
	23233880	CHEMBL4827568	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1nccc(-c2ccc(C(=O)O)c(C3CCCC3)c2)n1		CHEMBL4857601	=	Activity	%	8.0	CHEMBL5284	Homo sapiens	Activity	%	8.0
	23233881	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	Activity	%	4.0	CHEMBL5284	Homo sapiens	Activity	%	4.0
	23233882	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	Activity	%	6.0	CHEMBL5284	Homo sapiens	Activity	%	6.0
	23233883	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2cc(-c3ccccc3)cnc21		CHEMBL4859861	=	Activity	%	102.0	CHEMBL5284	Homo sapiens	Activity	%	102.0
	23233884	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2cccnc21		CHEMBL4853434	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	23233885	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4866741	=	Activity	%	46.0	CHEMBL5284	Homo sapiens	Activity	%	46.0
	23233886	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncccc23)cc1C1CCCC1		CHEMBL4861792	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
	23233887	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4875005	=	Activity	%	14.0	CHEMBL5284	Homo sapiens	Activity	%	14.0
	23233888	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncccc23)cc1C1CCCC1		CHEMBL4845793	=	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	23233889	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4851892	=	Activity	%	60.0	CHEMBL5284	Homo sapiens	Activity	%	60.0
	23233890	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	=	Activity	%	37.0	CHEMBL5284	Homo sapiens	Activity	%	37.0
	23233891	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	Activity	%	18.0	CHEMBL5284	Homo sapiens	Activity	%	18.0
	23233892	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3cccnc23)cc1C1CCCC1		CHEMBL4863514	=	Activity	%	65.0	CHEMBL5284	Homo sapiens	Activity	%	65.0
	23233893	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2nnc3ccc(-c4ccccc4)nn23)cc1C1CCCC1		CHEMBL4855365	=	Activity	%	72.0	CHEMBL5284	Homo sapiens	Activity	%	72.0
	23233894	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2nnc3cccnn23)cc1C1CCCC1		CHEMBL4846152	=	Activity	%	94.0	CHEMBL5284	Homo sapiens	Activity	%	94.0
	23233895	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	Activity	%	64.0	CHEMBL5284	Homo sapiens	Activity	%	64.0
	23233896	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	Cn1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4873692	=	Activity	%	30.0	CHEMBL5284	Homo sapiens	Activity	%	30.0
	23233897	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	Activity	%	8.0	CHEMBL5284	Homo sapiens	Activity	%	8.0
	23233898	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]cnc23)cc1C1CCCC1		CHEMBL4863974	=	Activity	%	66.0	CHEMBL5284	Homo sapiens	Activity	%	66.0
	23233899	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3cc(-c4ccccc4)sc23)cc1C1CCCC1		CHEMBL4854650	=	Activity	%	68.0	CHEMBL5284	Homo sapiens	Activity	%	68.0
	23233900	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	Activity	%	17.0	CHEMBL5284	Homo sapiens	Activity	%	17.0
	23233901	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4857706	=	Activity	%	75.0	CHEMBL5284	Homo sapiens	Activity	%	75.0
	23233902	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sccc23)cc1C1CCCC1		CHEMBL4853274	=	Activity	%	24.0	CHEMBL5284	Homo sapiens	Activity	%	24.0
	23233903	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4877634	=	Activity	%	62.0	CHEMBL5284	Homo sapiens	Activity	%	62.0
	23233904	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523	=	Activity	%	5.0	CHEMBL5284	Homo sapiens	Activity	%	5.0
	23233905	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4849143	=	Activity	%	28.0	CHEMBL5284	Homo sapiens	Activity	%	28.0
	23233906	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccccc23)cc1C1CCCC1		CHEMBL4878827	=	Activity	%	51.0	CHEMBL5284	Homo sapiens	Activity	%	51.0
	23233907	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	Cc1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2ccccc2n1		CHEMBL4865562	=	Activity	%	93.0	CHEMBL5284	Homo sapiens	Activity	%	93.0
	23233908	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccncc23)cc1C1CCCC1		CHEMBL4860464	=	Activity	%	91.0	CHEMBL5284	Homo sapiens	Activity	%	91.0
	23233909	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404	=	Activity	%	10.0	CHEMBL5284	Homo sapiens	Activity	%	10.0
	23233910	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(-c3ccccc3)n2)cc1C1CCCC1		CHEMBL4879358	=	Activity	%	84.0	CHEMBL5284	Homo sapiens	Activity	%	84.0
	23233911	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	=	Activity	%	21.0	CHEMBL5284	Homo sapiens	Activity	%	21.0
	23233912	CHEMBL4827569	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1nccc(-c2ccc(C(=O)O)c(C3CCCC3)c2)n1		CHEMBL4857601	=	Activity	%	53.0	CHEMBL5284	Homo sapiens	Activity	%	53.0
	23233913	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	Activity	%	14.0	CHEMBL5284	Homo sapiens	Activity	%	14.0
	23233914	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	Activity	%	83.0	CHEMBL5284	Homo sapiens	Activity	%	83.0
	23233915	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	Cn1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2cc(-c3ccccc3)cnc21		CHEMBL4859861	=	Activity	%	103.0	CHEMBL5284	Homo sapiens	Activity	%	103.0
	23233916	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	Cn1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2cccnc21		CHEMBL4853434	=	Activity	%	103.0	CHEMBL5284	Homo sapiens	Activity	%	103.0
	23233917	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4866741	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
	23233918	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncccc23)cc1C1CCCC1		CHEMBL4861792	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	23233919	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4875005	=	Activity	%	30.0	CHEMBL5284	Homo sapiens	Activity	%	30.0
	23233920	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncccc23)cc1C1CCCC1		CHEMBL4845793	=	Activity	%	101.0	CHEMBL5284	Homo sapiens	Activity	%	101.0
	23233921	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4851892	=	Activity	%	85.0	CHEMBL5284	Homo sapiens	Activity	%	85.0
	23233922	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	=	Activity	%	81.0	CHEMBL5284	Homo sapiens	Activity	%	81.0
	23233923	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	Activity	%	71.0	CHEMBL5284	Homo sapiens	Activity	%	71.0
	23233924	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3cccnc23)cc1C1CCCC1		CHEMBL4863514	=	Activity	%	100.0	CHEMBL5284	Homo sapiens	Activity	%	100.0
	23233925	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2nnc3ccc(-c4ccccc4)nn23)cc1C1CCCC1		CHEMBL4855365	=	Activity	%	91.0	CHEMBL5284	Homo sapiens	Activity	%	91.0
	23233926	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2nnc3cccnn23)cc1C1CCCC1		CHEMBL4846152	=	Activity	%	95.0	CHEMBL5284	Homo sapiens	Activity	%	95.0
	23233927	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	Activity	%	84.0	CHEMBL5284	Homo sapiens	Activity	%	84.0
	23233928	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	Cn1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4873692	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	23233929	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	Activity	%	78.0	CHEMBL5284	Homo sapiens	Activity	%	78.0
	23233930	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]cnc23)cc1C1CCCC1		CHEMBL4863974	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	23233931	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3cc(-c4ccccc4)sc23)cc1C1CCCC1		CHEMBL4854650	=	Activity	%	101.0	CHEMBL5284	Homo sapiens	Activity	%	101.0
	23233932	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	Activity	%	73.0	CHEMBL5284	Homo sapiens	Activity	%	73.0
	23233933	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4857706	=	Activity	%	91.0	CHEMBL5284	Homo sapiens	Activity	%	91.0
	23233934	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sccc23)cc1C1CCCC1		CHEMBL4853274	=	Activity	%	77.0	CHEMBL5284	Homo sapiens	Activity	%	77.0
	23233935	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4877634	=	Activity	%	92.0	CHEMBL5284	Homo sapiens	Activity	%	92.0
	23233936	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523	=	Activity	%	51.0	CHEMBL5284	Homo sapiens	Activity	%	51.0
	23233937	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4849143	=	Activity	%	48.0	CHEMBL5284	Homo sapiens	Activity	%	48.0
	23233938	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccccc23)cc1C1CCCC1		CHEMBL4878827	=	Activity	%	96.0	CHEMBL5284	Homo sapiens	Activity	%	96.0
	23233939	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	Cc1cc(-c2ccc(C(=O)O)c(C3CCCC3)c2)c2ccccc2n1		CHEMBL4865562	=	Activity	%	98.0	CHEMBL5284	Homo sapiens	Activity	%	98.0
	23233940	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccncc23)cc1C1CCCC1		CHEMBL4860464	=	Activity	%	102.0	CHEMBL5284	Homo sapiens	Activity	%	102.0
	23233941	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404	=	Activity	%	73.0	CHEMBL5284	Homo sapiens	Activity	%	73.0
	23233942	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(-c3ccccc3)n2)cc1C1CCCC1		CHEMBL4879358	=	Activity	%	98.0	CHEMBL5284	Homo sapiens	Activity	%	98.0
	23233943	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	=	Activity	%	97.0	CHEMBL5284	Homo sapiens	Activity	%	97.0
	23233944	CHEMBL4827570	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control	B	Nc1nccc(-c2ccc(C(=O)O)c(C3CCCC3)c2)n1		CHEMBL4857601	=	Activity	%	95.0	CHEMBL5284	Homo sapiens	Activity	%	95.0
	23233945	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	IC50	nM	3.0	CHEMBL5284	Homo sapiens	IC50	nM	3.0
	23233946	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	IC50	nM	26.0	CHEMBL5284	Homo sapiens	IC50	nM	26.0
	23233947	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2coc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4866741	=	IC50	nM	65.0	CHEMBL5284	Homo sapiens	IC50	nM	65.0
	23233948	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2csc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4875005	=	IC50	nM	5.0	CHEMBL5284	Homo sapiens	IC50	nM	5.0
	23233949	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4851892	=	IC50	nM	145.0	CHEMBL5284	Homo sapiens	IC50	nM	145.0
	23233950	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	=	IC50	nM	44.0	CHEMBL5284	Homo sapiens	IC50	nM	44.0
	23233951	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	IC50	nM	21.0	CHEMBL5284	Homo sapiens	IC50	nM	21.0
	23233952	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	IC50	nM	120.0	CHEMBL5284	Homo sapiens	IC50	nM	120.0
	23233953	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	Cn1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4873692	=	IC50	nM	56.0	CHEMBL5284	Homo sapiens	IC50	nM	56.0
	23233954	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	IC50	nM	23.0	CHEMBL5284	Homo sapiens	IC50	nM	23.0
	23233955	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]cnc23)cc1C1CCCC1		CHEMBL4863974	=	IC50	nM	193.0	CHEMBL5284	Homo sapiens	IC50	nM	193.0
	23233956	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3cc(-c4ccccc4)sc23)cc1C1CCCC1		CHEMBL4854650	=	IC50	nM	169.0	CHEMBL5284	Homo sapiens	IC50	nM	169.0
	23233957	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	IC50	nM	24.0	CHEMBL5284	Homo sapiens	IC50	nM	24.0
	23233958	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4857706	=	IC50	nM	232.0	CHEMBL5284	Homo sapiens	IC50	nM	232.0
	23233959	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3sccc23)cc1C1CCCC1		CHEMBL4853274	=	IC50	nM	31.0	CHEMBL5284	Homo sapiens	IC50	nM	31.0
	23233960	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4877634	=	IC50	nM	137.0	CHEMBL5284	Homo sapiens	IC50	nM	137.0
	23233961	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523	=	IC50	nM	13.0	CHEMBL5284	Homo sapiens	IC50	nM	13.0
	23233962	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4849143	=	IC50	nM	12.0	CHEMBL5284	Homo sapiens	IC50	nM	12.0
	23233963	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ncnc3ccccc23)cc1C1CCCC1		CHEMBL4878827	=	IC50	nM	96.0	CHEMBL5284	Homo sapiens	IC50	nM	96.0
	23233964	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404	=	IC50	nM	21.0	CHEMBL5284	Homo sapiens	IC50	nM	21.0
	23233965	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	=	IC50	nM	51.0	CHEMBL5284	Homo sapiens	IC50	nM	51.0
	23233966	CHEMBL4827571	Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control	B	Nc1nccc(-c2ccc(C(=O)O)c(C3CCCC3)c2)n1		CHEMBL4857601	=	IC50	nM	108.0	CHEMBL5284	Homo sapiens	IC50	nM	108.0
	23233967	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	Activity	%	2.8	CHEMBL5284	Homo sapiens	Activity	%	2.8
	23233968	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2coc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4866741	=	Activity	%	12.0	CHEMBL5284	Homo sapiens	Activity	%	12.0
	23233969	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	=	Activity	%	7.0	CHEMBL5284	Homo sapiens	Activity	%	7.0
	23233970	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	Activity	%	12.0	CHEMBL5284	Homo sapiens	Activity	%	12.0
	23233971	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	Activity	%	17.0	CHEMBL5284	Homo sapiens	Activity	%	17.0
	23233972	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	Activity	%	4.4	CHEMBL5284	Homo sapiens	Activity	%	4.4
	23233973	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	Activity	%	8.5	CHEMBL5284	Homo sapiens	Activity	%	8.5
	23233974	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4877634	=	Activity	%	18.0	CHEMBL5284	Homo sapiens	Activity	%	18.0
	23233975	CHEMBL4827572	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	=	Activity	%	9.4	CHEMBL5284	Homo sapiens	Activity	%	9.4
	23234013	CHEMBL4827592	Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	<	Activity	%	10.0	CHEMBL5284	Homo sapiens	Activity	%	10.0
	23234037	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	<	IC50	nM	3.0	CHEMBL5284	Homo sapiens	IC50	nM	3.0
Not Determined	23234038	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686		IC50			CHEMBL5284	Homo sapiens	IC50		
	23234039	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2coc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4866741	=	IC50	nM	700.0	CHEMBL5284	Homo sapiens	IC50	nM	700.0
	23234040	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2csc3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4875005	=	IC50	nM	210.0	CHEMBL5284	Homo sapiens	IC50	nM	210.0
	23234041	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4851892	=	IC50	nM	530.0	CHEMBL5284	Homo sapiens	IC50	nM	530.0
	23234042	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	=	IC50	nM	200.0	CHEMBL5284	Homo sapiens	IC50	nM	200.0
	23234043	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	IC50	nM	190.0	CHEMBL5284	Homo sapiens	IC50	nM	190.0
	23234044	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	IC50	nM	240.0	CHEMBL5284	Homo sapiens	IC50	nM	240.0
	23234045	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	Cn1ccc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4873692	=	IC50	nM	470.0	CHEMBL5284	Homo sapiens	IC50	nM	470.0
	23234046	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	IC50	nM	8.1	CHEMBL5284	Homo sapiens	IC50	nM	8.1
	23234047	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	IC50	nM	170.0	CHEMBL5284	Homo sapiens	IC50	nM	170.0
	23234048	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ncnc3sccc23)cc1C1CCCC1		CHEMBL4853274	=	IC50	nM	1400.0	CHEMBL5284	Homo sapiens	IC50	nM	1400.0
	23234049	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ccnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4877634	=	IC50	nM	540.0	CHEMBL5284	Homo sapiens	IC50	nM	540.0
	23234050	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523	=	IC50	nM	140.0	CHEMBL5284	Homo sapiens	IC50	nM	140.0
	23234051	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ncnc3ccc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL4849143	=	IC50	nM	890.0	CHEMBL5284	Homo sapiens	IC50	nM	890.0
	23234052	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ncnc3ccccc23)cc1C1CCCC1		CHEMBL4878827	=	IC50	nM	1900.0	CHEMBL5284	Homo sapiens	IC50	nM	1900.0
	23234053	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404	=	IC50	nM	290.0	CHEMBL5284	Homo sapiens	IC50	nM	290.0
	23234054	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	<	IC50	nM	3.0	CHEMBL5284	Homo sapiens	IC50	nM	3.0
	23234055	CHEMBL4827616	Inhibition of NanoLuc-fused CAMKK2 (unknown origin) expressed in HEK293 cells after 24 hrs by NanoBRET assay	B	Nc1nccc(-c2ccc(C(=O)O)c(C3CCCC3)c2)n1		CHEMBL4857601	=	IC50	nM	950.0	CHEMBL5284	Homo sapiens	IC50	nM	950.0
Active	23234090	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234091	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234092	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234093	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234094	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234095	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234096	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
Active	23234097	CHEMBL4827619	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 at 1 uM incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552		Inhibition	%		CHEMBL5284	Homo sapiens	INH		
	23234098	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2c[nH]c3ncccc23)cc1C1CCCC1		CHEMBL4125686	=	IC50	nM	5500.0	CHEMBL5284	Homo sapiens	IC50	nM	5500.0
	23234099	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	=	IC50	nM	900.0	CHEMBL5284	Homo sapiens	IC50	nM	900.0
	23234100	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	Cn1c(-c2ccccc2)cc2c(-c3ccc(C(=O)O)c(C4CCCC4)c3)ccnc21		CHEMBL4869147	=	IC50	nM	980.0	CHEMBL5284	Homo sapiens	IC50	nM	980.0
	23234101	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	=	IC50	nM	1800.0	CHEMBL5284	Homo sapiens	IC50	nM	1800.0
	23234102	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ncnc3ccsc23)cc1C1CCCC1		CHEMBL4862562	=	IC50	nM	8100.0	CHEMBL5284	Homo sapiens	IC50	nM	8100.0
	23234103	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccnc3ccccc23)cc1C1CCCC1		CHEMBL4852523	=	IC50	nM	390.0	CHEMBL5284	Homo sapiens	IC50	nM	390.0
	23234104	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccncn2)cc1C1CCCC1		CHEMBL4876404	=	IC50	nM	790.0	CHEMBL5284	Homo sapiens	IC50	nM	790.0
	23234105	CHEMBL4827620	Inhibition of CAMKK2 in human LNCaP C4-2 cells assessed as reduction AMPK phosphorylation at Thr172 incubated for 24 hrs by Western blot analysis	B	O=C(O)c1ccc(-c2ccnc(Nc3ccccc3)n2)cc1C1CCCC1		CHEMBL4857253	<	IC50	nM	39.0	CHEMBL5284	Homo sapiens	IC50	nM	39.0
Not Active	23317312	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	98.0	CHEMBL5284	Homo sapiens	% Control	%	98.0
Not Active	23317780	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	88.0	CHEMBL5284	Homo sapiens	% Control	%	88.0
Not Active	23318451	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23318930	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	97.0	CHEMBL5284	Homo sapiens	% Control	%	97.0
Not Active	23319569	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23320042	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	87.2	CHEMBL5284	Homo sapiens	% Control	%	87.2
Not Active	23320720	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	91.0	CHEMBL5284	Homo sapiens	% Control	%	91.0
Not Active	23321188	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23321818	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	93.0	CHEMBL5284	Homo sapiens	% Control	%	93.0
Not Active	23322286	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	84.0	CHEMBL5284	Homo sapiens	% Control	%	84.0
Not Active	23322975	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	96.0	CHEMBL5284	Homo sapiens	% Control	%	96.0
Not Active	23323443	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23324297	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	86.5	CHEMBL5284	Homo sapiens	% Control	%	86.5
Not Active	23324932	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	90.0	CHEMBL5284	Homo sapiens	% Control	%	90.0
Not Active	23325400	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23326047	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL5284	Homo sapiens	% Control	%	91.0
Not Active	23326515	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	89.0	CHEMBL5284	Homo sapiens	% Control	%	89.0
Not Active	23327215	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23327683	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	83.0	CHEMBL5284	Homo sapiens	% Control	%	83.0
Not Active	23328270	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	92.0	CHEMBL5284	Homo sapiens	% Control	%	92.0
Not Active	23328738	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	78.0	CHEMBL5284	Homo sapiens	% Control	%	78.0
Not Active	23329273	CHEMBL4880980	CaMKK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	102.0	CHEMBL5284	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23329684	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23330152	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23330908	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23331376	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23331963	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.0	CHEMBL5284	Homo sapiens	% Control	%	89.0
Not Active	23332431	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	99.6	CHEMBL5284	Homo sapiens	% Control	%	99.6
Not Active	23333147	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23333786	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23334254	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	82.0	CHEMBL5284	Homo sapiens	% Control	%	82.0
Not Active	23335233	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL5284	Homo sapiens	% Control	%	98.0
Not Active	23335701	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL5284	Homo sapiens	% Control	%	99.0
Not Active	23336328	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	91.0	CHEMBL5284	Homo sapiens	% Control	%	91.0
Not Active	23336796	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23337534	CHEMBL4881905	CAMKK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.0	CHEMBL5284	Homo sapiens	% Ctrl	%	98.0
Not Active	23337877	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23338345	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23338957	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23339425	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	56.0	CHEMBL5284	Homo sapiens	% Control	%	56.0
Not Active	23340062	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	75.0	CHEMBL5284	Homo sapiens	% Control	%	75.0
Not Active	23340530	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23341187	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23341655	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23342271	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	91.0	CHEMBL5284	Homo sapiens	% Control	%	91.0
Not Active	23342739	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23343369	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	95.0	CHEMBL5284	Homo sapiens	% Control	%	95.0
Not Active	23343837	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	80.0	CHEMBL5284	Homo sapiens	% Control	%	80.0
Not Active	23344475	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23345048	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23345516	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	95.0	CHEMBL5284	Homo sapiens	% Control	%	95.0
Not Active	23346093	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	69.7	CHEMBL5284	Homo sapiens	% Control	%	69.7
Not Active	23346562	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	91.5	CHEMBL5284	Homo sapiens	% Control	%	91.5
Not Active	23347172	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	75.2	CHEMBL5284	Homo sapiens	% Control	%	75.2
Not Active	23347653	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	85.4	CHEMBL5284	Homo sapiens	% Control	%	85.4
Not Active	23348232	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23348700	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23349287	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23349905	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23350373	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23350978	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23351446	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23351983	CHEMBL4882676	CAMKK2 (CaMKK beta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	19.79	CHEMBL5284	Homo sapiens	% Inhibition	%	19.7925
Not Active	23352470	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23352938	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	85.0	CHEMBL5284	Homo sapiens	% Control	%	85.0
Not Active	23353820	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23354288	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23355020	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23355488	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23356124	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23356592	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23357201	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	95.0	CHEMBL5284	Homo sapiens	% Control	%	95.0
Not Active	23357848	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	73.0	CHEMBL5284	Homo sapiens	% Control	%	73.0
Not Active	23358316	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23358902	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23359500	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23359968	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23360553	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	93.0	CHEMBL5284	Homo sapiens	% Control	%	93.0
Not Active	23361021	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23361594	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23362130	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23362598	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	91.0	CHEMBL5284	Homo sapiens	% Control	%	91.0
Not Active	23364240	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	81.0	CHEMBL5284	Homo sapiens	% Control	%	81.0
Not Active	23364708	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	99.0	CHEMBL5284	Homo sapiens	% Control	%	99.0
Not Active	23365447	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23365990	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	89.0	CHEMBL5284	Homo sapiens	% Control	%	89.0
Not Active	23366580	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23367048	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23367492	CHEMBL4883845	CAMKK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	97.0	CHEMBL5284	Homo sapiens	% Residual activity with Skepinone-L	%	97.0
Not Active	23367926	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL5284	Homo sapiens	% Control	%	93.0
Not Active	23368394	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23368993	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	77.0	CHEMBL5284	Homo sapiens	% Control	%	77.0
Not Active	23369461	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	88.0	CHEMBL5284	Homo sapiens	% Control	%	88.0
Not Active	23370001	CHEMBL4884245	CaMKK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	101.0	CHEMBL5284	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23370429	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	95.0	CHEMBL5284	Homo sapiens	% Control	%	95.0
Not Active	23370897	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23371706	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	88.0	CHEMBL5284	Homo sapiens	% Control	%	88.0
Not Active	23372174	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	78.0	CHEMBL5284	Homo sapiens	% Control	%	78.0
	23373714	CHEMBL4885491	CAMKK2(CAK2LGT5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5284	Homo sapiens	pIC50		6.0
Not Active	23374929	CHEMBL4885923	CAMKK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	8.5	CHEMBL5284	Homo sapiens	% Inhibition	%	8.5
Not Active	23375601	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23376069	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	91.0	CHEMBL5284	Homo sapiens	% Control	%	91.0
Not Active	23376647	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	90.0	CHEMBL5284	Homo sapiens	% Control	%	90.0
Not Active	23377116	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	95.0	CHEMBL5284	Homo sapiens	% Control	%	95.0
Not Active	23377974	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	76.0	CHEMBL5284	Homo sapiens	% Control	%	76.0
Not Active	23378442	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	99.0	CHEMBL5284	Homo sapiens	% Control	%	99.0
Not Active	23379609	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23380077	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23380771	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	94.0	CHEMBL5284	Homo sapiens	% Control	%	94.0
Not Active	23381419	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23381887	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
Not Active	23382511	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	68.0	CHEMBL5284	Homo sapiens	% Control	%	68.0
Not Active	23382979	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	69.0	CHEMBL5284	Homo sapiens	% Control	%	69.0
Not Active	23383722	CHEMBL4887371	CAMKK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL5284	Homo sapiens	% Ctrl	%	93.0
Not Active	23384208	CHEMBL4887803	CaMKK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	11.28	CHEMBL5284	Homo sapiens	% inhibition	%	11.28
Not Active	23384894	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	80.0	CHEMBL5284	Homo sapiens	% Control	%	80.0
Not Active	23385361	CHEMBL4879618	KinomeScan assay: inhibition of CAMKK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5284	Homo sapiens	% Control	%	100.0
